Detalhe da pesquisa
1.
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
Br J Haematol
; 200(2): 175-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214090
2.
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial.
Haematologica
; 107(12): 2859-2869, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615931
3.
Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications.
Am J Hematol
; 97(4): 431-439, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35049058
4.
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients.
Br J Haematol
; 194(2): 393-402, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34195988
5.
Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.
Br J Clin Pharmacol
; 86(5): 991-998, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912911
6.
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Biol Blood Marrow Transplant
; 25(9): 1803-1809, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128325
7.
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.
Blood
; 129(7): 846-854, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932374
8.
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Biol Blood Marrow Transplant
; 24(7): 1449-1454, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448057
9.
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group.
Cancer
; 124(14): 2956-2963, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29723417
10.
Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms.
Am J Hematol
; 93(3): 330-338, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29148089
11.
Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study.
Cancer
; 123(10): 1791-1799, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28026860
12.
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study.
Haematologica
; 102(8): 1368-1377, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522576
13.
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Biol Blood Marrow Transplant
; 20(10): 1560-5, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24933658
14.
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 20(3): 370-4, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24315846
15.
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission.
Blood
; 120(22): 4317-23, 2012 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23002117
16.
Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study.
Blood
; 119(11): 2474-7, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22267607
17.
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
J Immunol
; 188(9): 4701-8, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22467661
18.
[Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group)]. / Optimisation du bosutinib dans la leucémie myéloïde chronique : recommandations du Fi-LMC (France Intergroupe des leucémies myéloïdes chroniques).
Bull Cancer
; 111(1): 87-96, 2024 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-38087729
19.
Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study.
Leuk Res
; 139: 107481, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484432
20.
Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed acute myeloid leukemia.
Leuk Res
; 141: 107500, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636413